| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |